Blood Pressure Pattern among Adults in Lagos: Analysis of Data from Public Health Screenings
DOI:
https://doi.org/10.60787/njgp.v16i1.101Keywords:
Elevated blood pressure, hypertension, Lagos, NigeriaAbstract
Background: Knowledge of the pattern of blood pressure (BP) in a population is useful in documenting within-population differences in hypertension prevalence as well as identifying groups at increased risk of complications.
Materials and Methods: BP data obtained from 1061 participants in population screenings carried out in five local government areas within Lagos were analyzed. BPs were measured in both arms with individuals seated and the limb supported on a table by medical interns using a mercury sphygmomanometer. The higher of the two recordings was taken as the patient’s BP.
Results: The study population was made up of 54.5% feales with an overall mean age of 39.2 ± 15.0 years and a range of 18–84 years. Mean systolic and diastolic BPs increased significantly and progressively with age in both male and female participants. BP was elevated in 35.6% of the study population with 48.3% of those having moderate to severely elevated BP. The prevalence of elevated BP increased with age however, there was no significant difference in the prevalence of elevated BP between male and female participants. Between 11% and 20% of individuals aged 18–29 years had elevated BP, withthe proportion being much higher among males than females.
Conclusion: The study provides further evidence supporting the fact that hypertension is highly prevalent, is severe, and may have an onset earlier in life among African populations. There is need to institute polices focused on prevention, early detection, and prompt treatment of hypertension.
Downloads
References
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension
Optimal Treatment (HOT) randomised trial. HOT study group. Lancet 1998;351:1755‑62.
Chalmers J, Arima H. Management of hypertension: Evidence from the blood pressure lowering treatment trialists’ collaboration and from major clinical trials. Pol Arch Med Wewn 2009;119:373‑80.
Turnbull F, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527‑35.
Schillaci G, Vaudo G. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomized trials. Ital Heart J Suppl 2001;2:799‑802.
Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists’ collaboration. Lancet 2000;356:1955‑64.
Rampal L, Rampal S, Azhar MZ, Rahman AR. Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects. Public Health 2008;122:11‑8.
Centers for Disease Control and Prevention (CDC). Vital signs: Awareness and treatment of uncontrolled hypertension among adults – United States, 2003‑2010. MMWR Morb Mortal Wkly Rep 2012;61:703‑9.
Ekwunife OI. Prevalence, awareness, treatment and control of hypertension in a Nigerian population. Health 2010;2:731‑5.
Soyannwo MA, Ogbechi ME, Adeyeni GA, Soyeni AI, Lipede MR, Lucas AO, et al. Studies on the prevalence of renal disease and hypertension in relation to schistosomiasis. III. Proteinuria, haematuria, pyuria and bacteriuria in the rural community of Nigeria. Niger Med J 1978;8:451‑64.
Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997;87:160‑8.
Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: A systematic review. Hypertension 2007;50:1012‑8.
Cozier Y, Palmer JR, Horton NJ, Fredman L, Wise LA, Rosenberg L, et al. Racial discrimination and the incidence of hypertension in US black women. Ann Epidemiol 2006;16:681‑7.
Peer N, Steyn K, Lombard C, Gwebushe N, Levitt N. A high burden of hypertension in the urban black population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) study. PLoS One 2013;8:e78567.
Calhoun DA, Booth JN 3rd, Oparil S, Irvin MR, Shimbo D, Lackland DT, et al. Refractory hypertension: Determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. ypertension
;63:451‑8.
Wright JT Jr., Agodoa LY, Appel L, Cushman WC, Taylor AL, Obegdegbe GG, et al. New recommendations for treating hypertension in black patients: Evidence and/or consensus? Hypertension 2010;56:801‑3.
DouglasJG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, et al. Management of high blood pressure in African Americans: Consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003;163:525‑41.
Ulasi II, Ijoma CK. The enormity of chronic kidney disease in Nigeria: The situation in a teaching hospital in South-East Nigeria. J Trop Med 2010;2010:501957.
Kolo PM, Jibrin YB, Sanya EO, Alkali M, Peter Kio IB, Moronkola RK, et al. Hypertension-related admissions and outcome in a tertiary hospital in Northeast Nigeria. Int J Hypertens 2012;2012:960546.
Akinkugbe OO. Non-communicable Diseases in Nigeria. Final Report of a National Survey. Lagos, Nigeria: Ministry of Health and Social Services; 1997. p. 5‑41.
Abengowe CU. Cardiovascular disease in Northern Nigeria. Trop Geogr Med 1979;31:553‑60.
Adebayo RA, Balogun MO, Adedoyin RA, Obashoro-John OA, Bisiriyu LA, Abiodun OO, et al. Prevalence of hypertension in three rural communities of Ife North Local Government Area of Osun State, South West Nigeria. Int J Gen Med 2013;6:863‑8.
National Population Commission. Population Report by State; 2016. Available from: http://www.population.gov.ng/core-activities/surveys/dataset/2006-phc-priority-tables/. [Last accessed on 2017 Sep 25].
Rasaki R. Managing Metropolitan Lagos. A Speech delivered at the Inaugural Programme of the African Leadership Forum in Ota, Ogun State, Nigeria: October 24th to November 1st 1998. African Leadership Forum; 1988. p. 1‑30.
Chalmers J. The WHO-ISH Hypertension Guidelines Committee. 1999 World Health Organization-International Society Of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151‑83.
Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, Quach S, et al. Blood pressure in Canadian adults. Health Rep 2010;21:37‑46.
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363‑9.
Banegas JR, Rodríguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillón P, del Rey Calero J. Blood pressure in spain: Distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998;32:998‑1002.
Ulasi II, Ijoma CK, Onwubere BJ, Arodiwe E, Onodugo O, Okafor C, et al. High prevalence and low awareness of hypertension in a market population in Enugu, Nigeria. Int J Hypertens 2011;2011:869675.
Isezuo SA, Sabir AA, Ohwovorilole AE, Fasanmade OA. Prevalence, associated factors and relationship between prehypertension and hypertension: A study of two ethnic African populations in Northern Nigeria. J Hum Hypertens 2011;25:224‑30.
Adediran OS, Okpara IC, Adeniyi OS, Jimoh AK. Hypertension prevalence in an urban and rural area of Nigeria. J Med Med Sci 2013;4:149‑54.
Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria: A systematic review and meta‑analysis. J Hypertens 2015;33:230‑42.
Akinlua JT, Meakin R, Umar AM, Freemantle N. Current prevalence pattern of hypertension in Nigeria: A Systematic review. PLoS One 2015;10:e0140021.
Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol 2012;4:327‑40.
Adedoyin RA, Mbada CE, Balogun MO, Martins T, Adebayo RA, Akintomide A, et al. Prevalence and pattern of hypertension in a semiurban community in Nigeria. Eur J Cardiovasc Prev Rehabil 2008;15:683‑7.
Lawoyin TO, Asuzu MC, Kaufman J, Rotimi C, Owoaje E, Johnson L, et al. Prevalence of cardiovascular risk factors in an African, urban inner city community. West Afr J Med 2002;21:208‑11.
Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J 1997;74:299‑302.
Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746‑53.
Skrobonja A, Kontosic I. Arterial hypertension in correlation with age and body mass index in some occupational groups in the harbour of Rijeka, Croatia. Ind Health 1998;36:312‑7.
McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol 2007;34:665‑71.
O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990;15:339‑47.
Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: An age‑old debate. Hypertension 2008;51:952‑9.
Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: Data from NHANES III.J Gend Specif Med 2001;4:10‑3, 20.
Daugherty SL, Masoudi FA, EllisJL, Ho PM, SchmittdielJA, Tavel HM, et al. Age-dependent gender differences in hypertension management. J Hypertens 2011;29:1005‑11.
Niiranen TJ, Rissanen H, Johansson JK, JulaAM. Overall cardiovascular prognosis of isolated systolic hypertension, isolated diastolic hypertension and pulse pressure defined with home measurements: The
finn‑home study. J Hypertens 2014;32:518‑24.
Li Y, Wei FF, Wang S, Cheng YB, Wang JG. Cardiovascular risks associated with diastolic blood pressure and isolated diastolic hypertension. Curr Hypertens Rep 2014;16:489.
Protogerou AD, Blacher J, Safar ME. Isolated systolic hypertension: ‘to treat or not to treat’ and the role of central haemodynamics. J Hypertens 2013;31:655‑8.
O’Rourke MF, Adji A. Guidelines on guidelines: Focus on isolated systolic hypertension in youth. J Hypertens 2013;31:649‑54.
McEniery CM, Franklin SS, Wilkinson IB, Cockcroft JR. Isolated systolic hypertension in the young: A need for clarity. J Hypertens 2013;31:1911‑3.
O’Rourke MF, Adji A. Isolated systolic hypertension in the young: A need for clarity. Reply. J Hypertens 2013;31:1913‑4.
Published
Issue
Section
License
Copyright (c) 2024 Nigerian Journal of General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
